Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.
Ozols RF
Controversies in the management of ovarian cancer
International Journal of Gynecological Cancer (1997) 7:27-32.
Abstract
A new standard chemotherapy for ovarian cancer has been accepted in the USA: paclitaxel (Taxol(R)) plus a platinum compound (cisplatin or carboplatin). There remain, however, many areas of controversy in treating this disease, including the role of cytoreductive surgery, the optimum combination regimen, the approach to managing patients who achieve a clinical remission, the importance of dose intensity in chemotherapy, the efficacy of intraperitoneal therapy, the benefit of whole-abdomen irradiation, and the status of immunotherapy and hormones.
Note
Publication Date: 1997-05-01.
Back
Last updated on Saturday, June 06, 2020